Literature DB >> 1315739

A comparison of three heparin-binding serine proteinase inhibitors.

C W Pratt1, H C Whinna, F C Church.   

Abstract

The purpose of this study was to compare three heparin-binding plasma proteinase inhibitors in order to identify common and unique features of heparin binding and heparin-enhanced proteinase inhibition. Experiments with antithrombin, heparin cofactor, and protein C inhibitor were performed under identical conditions in order to facilitate comparisons. Synthetic peptides corresponding to the putative heparin binding regions of antithrombin, heparin cofactor, and protein C inhibitor bound to heparin directly and interfered in heparin-enhanced proteinase inhibition assays. All three inhibitors obeyed a ternary complex mechanism for heparin-enhanced thrombin inhibition, and the optimum heparin concentration was related to the apparent heparin affinity of the inhibitor. The maximum inhibition rate and rate enhancement due to heparin appeared to be unique properties of each inhibitor. In assays with heparin oligosaccharides of known size, only the antithrombin-thrombin reaction exhibited a sharp threshold for rate enhancement at 14-16 saccharide units. Acceleration of antithrombin inhibition of factor Xa, heparin cofactor inhibition of thrombin, and protein C inhibitor inhibition of thrombin, activated protein C, and factor Xa did not require a minimum saccharide size. The differences in heparin size dependence and rate enhancement of proteinase inhibition by these inhibitors might reflect differences in the importance of the ternary complex mechanism and other mechanisms, alterations in inhibitor reactivity, and orientation effects in heparin-enhanced proteinase inhibition.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1315739

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Molecular basis of thrombin recognition by protein C inhibitor revealed by the 1.6-A structure of the heparin-bridged complex.

Authors:  Wei Li; Ty E Adams; Jyoti Nangalia; Charles T Esmon; James A Huntington
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-24       Impact factor: 11.205

2.  Proteolytic activation transforms heparin cofactor II into a host defense molecule.

Authors:  Martina Kalle; Praveen Papareddy; Gopinath Kasetty; Douglas M Tollefsen; Martin Malmsten; Matthias Mörgelin; Artur Schmidtchen
Journal:  J Immunol       Date:  2013-05-08       Impact factor: 5.422

3.  Glycosaminoglycan-binding properties and kinetic characterization of human heparin cofactor II expressed in Escherichia coli.

Authors:  Suryakala Sarilla; Sally Y Habib; Douglas M Tollefsen; David B Friedman; Diana R Arnett; Ingrid M Verhamme
Journal:  Anal Biochem       Date:  2010-07-27       Impact factor: 3.365

4.  Interaction of activated protein C with serpins.

Authors:  J M Hermans; S R Stone
Journal:  Biochem J       Date:  1993-10-01       Impact factor: 3.857

5.  A peptide-model for the heparin-binding property of pseudorabies virus glycoprotein III.

Authors:  D Sawitzky; A Voigt; K O Habermehl
Journal:  Med Microbiol Immunol       Date:  1993-12       Impact factor: 3.402

6.  Engineering D-helix of antithrombin in alpha-1-proteinase inhibitor confers antiinflammatory properties on the chimeric serpin.

Authors:  L Yang; P Dinarvand; S H Qureshi; A R Rezaie
Journal:  Thromb Haemost       Date:  2014-02-13       Impact factor: 5.249

7.  Binding of insulin-like growth factor (IGF)-binding protein-5 to smooth-muscle cell extracellular matrix is a major determinant of the cellular response to IGF-I.

Authors:  A Parker; C Rees; J Clarke; W H Busby; D R Clemmons
Journal:  Mol Biol Cell       Date:  1998-09       Impact factor: 4.138

8.  Heparin enhances serpin inhibition of the cysteine protease cathepsin L.

Authors:  Wayne J Higgins; Denise M Fox; Piotr S Kowalski; Jens E Nielsen; D Margaret Worrall
Journal:  J Biol Chem       Date:  2009-12-03       Impact factor: 5.157

9.  Mutagenesis studies toward understanding the intracellular signaling mechanism of antithrombin.

Authors:  J-S Bae; A R Rezaie
Journal:  J Thromb Haemost       Date:  2009-03-06       Impact factor: 5.824

10.  Mutation of the H-helix in antithrombin decreases heparin stimulation of protease inhibition.

Authors:  Patrick R Gonzales; Timothy D Walston; Laureano O Camacho; Dana M Kielar; Frank C Church; Alireza R Rezaie; Scott T Cooper
Journal:  Biochim Biophys Acta       Date:  2007-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.